Facebook Pixel Healthify bets on weight loss drugs amid rise of obesity | Mint Bangalore - newspaper - Read this story on Magzter.com
Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

Healthify bets on weight loss drugs amid rise of obesity

Mint Bangalore

|

May 02, 2025

Nutrition-tracking platform Healthify is banking on weight loss drugs to boost growth, anticipating demand for these medicines to boom in India.

- Jessica Jani

The company is increasing its offerings to incorporate GLP-1 drugs such as Ozempic and Mounjaro—used to treat type 2 diabetes and, in some cases, obesity—and expects revenue from its GLP-1 companion programmes to exceed Healthify's main revenue in three to four years, Tushar Vashisht, co-founder and chief executive officer, told Mint in an interview.

The healthtech firm, which started out as a calorie and nutrition-tracking app, expects demand for weight-loss drugs to surge in India.

MORE STORIES FROM Mint Bangalore

Mint Bangalore

States bet on trees to lift farm incomes

Several Indian states plan to integrate trees into mainstream farming systems to improve soil health, capture atmospheric carbon, and diversify rural livelihoods, as crop yields drop due to climate change and land degradation.

time to read

1 min

February 27, 2026

Mint Bangalore

Office leasing is in a good space

Grade-A office spaces are seeing faster absorption buoyed by favourable demand-supply dynamics, thus pushing vacancies lower.

time to read

2 mins

February 27, 2026

Mint Bangalore

Mint Bangalore

How artificial intelligence alters India's challenge of employment

A three-pillar strategy outlined for the country must now take into account the impact that AI may have on job availability

time to read

4 mins

February 27, 2026

Mint Bangalore

Canara Bank raises ₹5,000 crore

State-run lender Canara Bank on Thursday raised ₹5,000 crore through a bond sale.

time to read

1 min

February 27, 2026

Mint Bangalore

Mint Bangalore

Easier share exits for investors of GIFT City listed firms likely

Likely permission for secondary market sale aims to attract public listings, improve liquidity

time to read

2 mins

February 27, 2026

Mint Bangalore

Mint Bangalore

Solar exporters shift focus to Africa

With a new duty slapped on solar module exports to the US, Africa may become an alternative destination for India-made solar power equipment, a government official said.

time to read

2 mins

February 27, 2026

Mint Bangalore

Mint Bangalore

India-Israel ties a 'special strategic partnership' now

The countries have also agreed to fast-track a long-awaited bilateral free trade agreement

time to read

1 mins

February 27, 2026

Mint Bangalore

Mint Bangalore

RBI’s prop trading curbs may buoy foreign traders

market intermediaries under banks’ overall capital market exposure framework, to prevent banks from lending depositor money for speculative trading, especially in weekly index options.

time to read

3 mins

February 27, 2026

Mint Bangalore

Mint Bangalore

Nvidia sales outlook gets bearish investor response

Nvidia Corp.'s latest sales forecast drew a bearish response from investors, signaling that concerns over a potential bubble continue to weigh on the dominant maker of artificial intelligence processors.

time to read

1 mins

February 27, 2026

Mint Bangalore

Mint Bangalore

Opt for broad-based market indices over passive investing themes’

How can investors select simple and suitable passive funds for their portfolios?

time to read

3 mins

February 27, 2026

Listen

Translate

Share

-
+

Change font size